Cargando…
Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis
Intrahepatic cholestasis in pregnancy (ICP) represents, depending on its severity, a serious risk for the fetus. Those cases with unusually high bile acid levels may be resistant to pharmaceutical treatment and can be treated with plasma exchange or albumin dialysis. However, the success rate of the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830103/ https://www.ncbi.nlm.nih.gov/pubmed/35135789 http://dx.doi.org/10.1136/bcr-2021-246318 |
_version_ | 1784648208855597056 |
---|---|
author | Lia, Massimiliano Berg, Thomas Weydandt, Laura Christina Stepan, Holger |
author_facet | Lia, Massimiliano Berg, Thomas Weydandt, Laura Christina Stepan, Holger |
author_sort | Lia, Massimiliano |
collection | PubMed |
description | Intrahepatic cholestasis in pregnancy (ICP) represents, depending on its severity, a serious risk for the fetus. Those cases with unusually high bile acid levels may be resistant to pharmaceutical treatment and can be treated with plasma exchange or albumin dialysis. However, the success rate of these therapeutic options and the factors influencing therapeutic response are unknown. Furthermore, if these options fail to improve ICP and serum bile acid levels are very high (>200 μm/L), there are no clear recommendations when delivery should be planned. Here, we report a patient with severe ICP resistant to both therapeutic plasma exchange and albumin dialysis. Caesarean section was performed at 32 weeks of gestation followed by rapid remission of ICP. |
format | Online Article Text |
id | pubmed-8830103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-88301032022-02-22 Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis Lia, Massimiliano Berg, Thomas Weydandt, Laura Christina Stepan, Holger BMJ Case Rep Case Reports: Learning from unexpected outcome (positive or negative) Intrahepatic cholestasis in pregnancy (ICP) represents, depending on its severity, a serious risk for the fetus. Those cases with unusually high bile acid levels may be resistant to pharmaceutical treatment and can be treated with plasma exchange or albumin dialysis. However, the success rate of these therapeutic options and the factors influencing therapeutic response are unknown. Furthermore, if these options fail to improve ICP and serum bile acid levels are very high (>200 μm/L), there are no clear recommendations when delivery should be planned. Here, we report a patient with severe ICP resistant to both therapeutic plasma exchange and albumin dialysis. Caesarean section was performed at 32 weeks of gestation followed by rapid remission of ICP. BMJ Publishing Group 2022-02-08 /pmc/articles/PMC8830103/ /pubmed/35135789 http://dx.doi.org/10.1136/bcr-2021-246318 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Reports: Learning from unexpected outcome (positive or negative) Lia, Massimiliano Berg, Thomas Weydandt, Laura Christina Stepan, Holger Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title | Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title_full | Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title_fullStr | Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title_full_unstemmed | Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title_short | Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
title_sort | intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis |
topic | Case Reports: Learning from unexpected outcome (positive or negative) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830103/ https://www.ncbi.nlm.nih.gov/pubmed/35135789 http://dx.doi.org/10.1136/bcr-2021-246318 |
work_keys_str_mv | AT liamassimiliano intrahepaticcholestasisofpregnancyresistanttoboththerapeuticplasmaexchangeandalbumindialysis AT bergthomas intrahepaticcholestasisofpregnancyresistanttoboththerapeuticplasmaexchangeandalbumindialysis AT weydandtlaurachristina intrahepaticcholestasisofpregnancyresistanttoboththerapeuticplasmaexchangeandalbumindialysis AT stepanholger intrahepaticcholestasisofpregnancyresistanttoboththerapeuticplasmaexchangeandalbumindialysis |